Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11204920rdf:typepubmed:Citationlld:pubmed
pubmed-article:11204920lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:11204920lifeskim:mentionsumls-concept:C0205721lld:lifeskim
pubmed-article:11204920lifeskim:mentionsumls-concept:C0085393lld:lifeskim
pubmed-article:11204920pubmed:issue10lld:pubmed
pubmed-article:11204920pubmed:dateCreated2001-2-6lld:pubmed
pubmed-article:11204920pubmed:abstractTextImmunocompromised children are at high risk for developing nosocomial infections which may cause significant morbidity and mortality in this population. In paediatric oncology, reported prevalence of nosocomial infections varies from 10 to 20%. Major predisposing factors are neutropenia, central venous catheter, corticosteroid therapy and hospital construction or renovation for invasive aspergillosis. The management of patients with febrile neutropenia should take into account the previous history of infection and the microbiologic environment of each department. Nowadays, Gram positives infections are predominant, but fungal infections remain a major threat. In organ transplant recipients, wound infections are the main early problems, followed by viral infections often due to the donor CMV seropositivity. In HIV-infected children, nosocomial infections are difficult to define, and can implicate unusual pathogens. In general, adapted preventive infection control strategy warrants prospective studies.lld:pubmed
pubmed-article:11204920pubmed:languagefrelld:pubmed
pubmed-article:11204920pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11204920pubmed:citationSubsetIMlld:pubmed
pubmed-article:11204920pubmed:statusMEDLINElld:pubmed
pubmed-article:11204920pubmed:monthDeclld:pubmed
pubmed-article:11204920pubmed:issn0369-8114lld:pubmed
pubmed-article:11204920pubmed:authorpubmed-author:LevergerGGlld:pubmed
pubmed-article:11204920pubmed:authorpubmed-author:TaboneM DMDlld:pubmed
pubmed-article:11204920pubmed:authorpubmed-author:Vu ThienHHlld:pubmed
pubmed-article:11204920pubmed:authorpubmed-author:MoissenetDDlld:pubmed
pubmed-article:11204920pubmed:issnTypePrintlld:pubmed
pubmed-article:11204920pubmed:volume48lld:pubmed
pubmed-article:11204920pubmed:ownerNLMlld:pubmed
pubmed-article:11204920pubmed:authorsCompleteYlld:pubmed
pubmed-article:11204920pubmed:pagination893-900lld:pubmed
pubmed-article:11204920pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11204920pubmed:meshHeadingpubmed-meshheading:11204920...lld:pubmed
pubmed-article:11204920pubmed:meshHeadingpubmed-meshheading:11204920...lld:pubmed
pubmed-article:11204920pubmed:meshHeadingpubmed-meshheading:11204920...lld:pubmed
pubmed-article:11204920pubmed:meshHeadingpubmed-meshheading:11204920...lld:pubmed
pubmed-article:11204920pubmed:meshHeadingpubmed-meshheading:11204920...lld:pubmed
pubmed-article:11204920pubmed:meshHeadingpubmed-meshheading:11204920...lld:pubmed
pubmed-article:11204920pubmed:meshHeadingpubmed-meshheading:11204920...lld:pubmed
pubmed-article:11204920pubmed:meshHeadingpubmed-meshheading:11204920...lld:pubmed
pubmed-article:11204920pubmed:year2000lld:pubmed
pubmed-article:11204920pubmed:articleTitle[Nosocomial infections in immunocompromised children].lld:pubmed
pubmed-article:11204920pubmed:affiliationService d'hématologie et d'oncologie pédiatrique, hôpital d'enfants Armand-Trousseau, 26 avenue du Dr-A. Netter, 75012 Paris, France. hemato-onco-ped.trousseau@trs.ap-hop-paris.frlld:pubmed
pubmed-article:11204920pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11204920pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:11204920pubmed:publicationTypeReviewlld:pubmed